empagliflozin effect in polycystic ovarian syndrom
Phase 3
Recruiting
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20220822055771N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
women between 15-55 years old
polycystic ovarian syndrom
Exclusion Criteria
Glomerular filtration rate<30
pregnant
liver disease
diabet mellitus
urinary tract infection
chronic disease
on hypertention treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method